This study aimed to evaluate the feasibility of VX2 tumor in rabbit auricles as an experimental model for intra-arterial embolization. This study was approved by our Institutional Animal Care and Use Committee. VX2 tumors were implanted in both auricles of 12 New Zealand White Rabbits. To investigate the angiographic and pathologic characteristics, angiography, ultrasonography, and thermography were performed 1-2 weeks after inoculation, and image analysis was performed. The animals were sacrificed thereafter, and histologic analysis was conducted by a pathologist. Tumors did not grow in 3/24 auricles of 12 rabbits used in the experiment, and one rabbit died during anesthesia for an ultrasonographic examination. Therefore, images were obtained from a total of 19 auricles. Angiography was successfully performed in 11 rabbits, and hypervascularity and tumor feeding vessels were clearly observed in all tumors. The enhancement effect increased significantly as the volume increased. In histologic evaluation, the average area of necrosis was 27%. In conclusion, a rabbit auricular VX2 tumor model is easy to create, and its features can be conveniently observed on visual inspection. Moreover, it appears hypervascular on angiography, and the tumor feeding vessel is easy to approach. Thus, it is useful for studying intra-arterial embolization.
Download full-text PDF |
Source |
---|---|
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0316282 | PLOS |
PLoS One
January 2025
Department of Radiology, Chung-Ang University Gwangmyeong Hospital, Seoul, Republic of Korea.
This study aimed to evaluate the feasibility of VX2 tumor in rabbit auricles as an experimental model for intra-arterial embolization. This study was approved by our Institutional Animal Care and Use Committee. VX2 tumors were implanted in both auricles of 12 New Zealand White Rabbits.
View Article and Find Full Text PDFFront Pharmacol
January 2025
Department of Ultrasound, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
Introduction: Tumor tissues exhibit significantly lower oxygen partial pressure compared to normal tissues, leading to hypoxia in the tumor microenvironment and result in resistance to tumor treatments. Strategies to mitigate hypoxia include enhancing blood perfusion and oxygen supply, for example,by decomposing hydrogen peroxide within the tumor. Improving hypoxia in the tumor microenvironment could potentially improve the efficacy of cancer treatments.
View Article and Find Full Text PDFCell Transplant
January 2025
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
The trans-vessel wall device (TW-device) is a new endovascular tool for precise and safe delivery of various payloads (cells, viral, modified RNA, chemotherapy, growth factors) in oncology and regenerative medicine. The twofold aim of this study was to assess cell engraftment and tumor growth using the TW-device for endovascular transplantation and to evaluate its ability to directly access solid tumors. We used the VX2 model in the rabbit kidney to compare percutaneously implanted fresh VX2 cells with TW-device injections of cryopreserved VX2 cells.
View Article and Find Full Text PDFJ Ultrasound Med
January 2025
Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA.
Objective: Focused ultrasound has emerged as a precise and minimally invasive modality for effective cancer treatment. In this study, we propose a novel method that integrates the mechanical effects of focused ultrasound, known as histotripsy, with heating to enhance both the immediate and sustained cytotoxic effects on cancer cells.
Methods: Our investigation focused on VX2 cancer cells in suspension, examining five experimental groups: blank control, negative control, heating alone, histotripsy alone, and histotripsy with subsequent heating.
Cancer Prev Detect Interv (2024)
October 2024
Magnetic resonance guided focused ultrasound (MRgFUS) is one of the most attractive emerging minimally invasive procedures for breast cancer, which induces localized hyperthermia, resulting in tumor cell death. Accurately assessing the post-ablation viability of all treated tumor tissue and surrounding margins immediately after MRgFUS thermal therapy residual tumor tissue is essential for evaluating treatment efficacy. While both thermal and vascular MRI-derived biomarkers are currently used to assess treatment efficacy, currently, no adequately accurate methods exist for the in vivo determination of tissue viability during treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!